- Home
- RPRX vs PNR Comparison
RPRX vs PNR Comparison
Compare RPRX & PNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- PNR
- Stock Information
- Founded
- RPRX 1996
- PNR 1966
- Country
- RPRX United States
- PNR United Kingdom
- Employees
- RPRX N/A
- PNR N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- PNR Industrial Machinery/Components
- Sector
- RPRX Health Care
- PNR Industrials
- Exchange
- RPRX Nasdaq
- PNR Nasdaq
- Market Cap
- RPRX 13.9B
- PNR 15.8B
- IPO Year
- RPRX 2020
- PNR N/A
- Fundamental
- Price
- RPRX $36.46
- PNR $106.87
- Analyst Decision
- RPRX Strong Buy
- PNR Buy
- Analyst Count
- RPRX 3
- PNR 16
- Target Price
- RPRX $47.33
- PNR $107.53
- AVG Volume (30 Days)
- RPRX 4.4M
- PNR 1.2M
- Earning Date
- RPRX 08-07-2025
- PNR 07-22-2025
- Dividend Yield
- RPRX 2.42%
- PNR 0.94%
- EPS Growth
- RPRX 37.60
- PNR 2.96
- EPS
- RPRX 2.45
- PNR 3.87
- Revenue
- RPRX $2,263,845,000.00
- PNR $4,076,000,000.00
- Revenue This Year
- RPRX $29.35
- PNR $2.18
- Revenue Next Year
- RPRX $7.58
- PNR $4.10
- P/E Ratio
- RPRX $14.83
- PNR $27.61
- Revenue Growth
- RPRX 1.13
- PNR N/A
- 52 Week Low
- RPRX $24.05
- PNR $73.45
- 52 Week High
- RPRX $36.43
- PNR $110.71
- Technical
- Relative Strength Index (RSI)
- RPRX 64.64
- PNR 72.67
- Support Level
- RPRX $35.01
- PNR $101.83
- Resistance Level
- RPRX $36.33
- PNR $104.08
- Average True Range (ATR)
- RPRX 0.63
- PNR 1.85
- MACD
- RPRX 0.05
- PNR 0.62
- Stochastic Oscillator
- RPRX 90.72
- PNR 97.61
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Pentair's business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.1 billion in revenue in 2024.